Kestrel

NP47827 Multiple Sclerosis Medicines

The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · published Mon 26 Oct 2026

In plain English

Reading the notice and writing a summary. This takes a few seconds the first time.

Who holds it now

Last won by Merck Sharp & Dohme UK Ltd and Aventis Pharma Ltd Trading As Sanofi and Crescent Pharma Limited and 23 more in Sep 2026, for £61.8m.

What you're up against

  • The last two awards went to different firms: this buyer has changed supplier before.
  • 35 different firms won this buyer's 3 awards for this kind of work in 2026.
  • It last went for £61.8m in 2026.
  • The last award named 26 suppliers: it may be a framework, where many firms are chosen.

From The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)'s earlier award notices for the same kind of work. The tender documents usually say which contract this one replaces.

The documents are on Public Contracts Scotland, where the bid is sent too. It's free to register there.

The notice as published

The Authority seeks to establish a Framework Agreement covering Multiple Sclerosis medicines. The range of medicines under consideration for inclusion in the Framework Agreement are listed below (subject to removal or replacement due to a continually shifting litigation landscape): Glatiramer acetate Interferon beta-1a Teriflunomide Dimethyl fumarate Fingolimod Natalizumab Cladribine Supply of Glatiramer acetate, Interferon beta-1a and Natalizumab to NHS Scotland. The Authority intends to award this Lot as an unranked multi supplier Framework Agreement per product line. Full details of Goods and volumes will be found within the ITT documents once published. Supply of cladribine tablets to NHS Scotland. The Authority intends to award this Lot as a ranked multi-supplier Framework Agreement per product line. Full details of Goods and volumes will be found within the ITT documents once published. Supply of Fingolimod, Teriflunomide and Dimethyl Fumarate to NHS Scotland. The Authority intends to award this Lot as a ranked multi-supplier Framework Agreement per product line. Full details of Goods and volumes will be found within the ITT documents once published.